Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

Published on by Book of Award

Mrs. Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

University of Fribourg | Switzerland

Mrs. Sophie Grigolo is an emerging researcher specializing in cellular and molecular biology, with a strong focus on cancer research, particularly clear-cell renal-cell carcinoma (ccRCC). Her work encompasses extensive laboratory expertise in cell culture using human kidney cancer cell lines (A-498, ACHN, Caki-1, and Caki-2) and a range of analytical assays including BrdU Cell Proliferation, MTT, LDH, and Live-or-Dye™ Fixable Viability Staining. She is proficient in advanced molecular biology techniques such as polymerase chain reaction (PCR), agarose gel electrophoresis, western blotting, genotyping, flow cytometry, and immunohistochemistry (IHC), which she applies to elucidate cancer cell behavior and therapeutic responses. Her publications, including studies on immunotherapy in ccRCC and the role of IL-2 receptor expression in renal carcinoma cells, contribute to advancing understanding of tumor immunology and targeted therapies. Sophie has also shared her findings at prestigious scientific forums, including the International Student Congress of (bio)Medical Sciences and the Annual European Student Symposium on Anatomical Research, where her work has earned recognition for excellence. Through her research and technical acumen, she continues to contribute to the evolving field of cancer biology and the development of innovative therapeutic approaches.

Profile : Orcid

Featured Publications

Grigolo, S., Fellay, I., & Filgueira, L. (2025). IL-2 receptor expression in renal cell carcinoma cells: IL-2 influences cell survival and induces cell death. Current Issues in Molecular Biology, 47(10), 830.

Grigolo, S., & Filgueira, L. (2024). Immunotherapy of clear-cell renal-cell carcinoma. Cancers, 16, 2092.

Valentina Mihaylova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Mrs. Valentina Mihaylova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Medical University-Plovdiv | Bulgaria

Mrs. Valentina Mihaylova is a dedicated researcher and specialist in medical chemistry with a strong focus on cellular metabolism, mitochondrial function, oxidative stress, and autoimmune diseases. With an h-index of 2, she has authored five scientific publications, which have collectively garnered 14 citations, reflecting her growing impact in medical biology and clinical research. Her work encompasses the study of markers of oxidative stress and insulin resistance in chronic autoimmune Hashimoto’s thyroiditis, cellular metabolic profiling in children with autism spectrum disorders, and the evaluation of therapeutic effects in rheumatoid arthritis through mitochondrial function and bioenergetic metabolism. Mrs. Mihaylova’s research also explores intestinal permeability, systemic inflammation, and the pharmacological effects of treatments such as methotrexate and JAK inhibitors on mitochondrial function and oxidative stress. She has actively contributed to numerous national and international conferences, presenting pioneering findings on the role of mitochondria, autophagy, and inflammation in autoimmune and rheumatologic conditions. Her academic and professional trajectory, spanning positions from clinical chemist to Master of Medical Chemistry at the Medical University of Plovdiv, is marked by a commitment to advancing knowledge in medical biology and translational research. Through her multidisciplinary approach, Mrs. Mihaylova continues to elucidate complex biochemical mechanisms underlying disease pathology and therapeutic responses, establishing herself as an emerging contributor to the field of medical and clinical biochemistry.

Profiles : Scopus | Orcid

Featured Publications

Mihaylova, V., Tomov, D., Karalilova, R., Batalov, Z., Batalov, A., Sarafian, V., & Kazakova, M. (2025). Effects of methotrexate and tofacitinib on mitochondrial function and oxidative stress in human synovial cells in vitro. International Journal of Molecular Sciences, 26(17), 8173.

Tomov, D. G., Levterova, B. A., Mihaylova, V. N., Troev, D. M., Miteva, M. Z., Uzunova, Y. I., & Orbetzova, M. M. (2024). Influence of the increase in intestinal permeability and microbiota change in the development of Hashimoto's thyroiditis: A systematic review. Endocrine and Metabolic Science, 100195.

Mihaylova, V., Kazakova, M., Batalov, Z., Karalilova, R., Batalov, A., & Sarafian, V. (2023). JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: A pilot study. Rheumatology International.

Adarsh Kumar Shukla | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Adarsh Kumar Shukla | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Dr. Bhimrao Ramji Ambedkar Government Medical College | India

Author Profile

Scopus

Orcid

Google Scholar

 

Early Academic Pursuits

Dr. Adarsh Kumar Shukla laid the foundation of his academic journey with a strong inclination towards life sciences and biological research. Beginning with a degree in Biotechnology, he cultivated a passion for understanding molecular processes and biological systems. His interest in computational and applied biological sciences further deepened during his Master’s studies in Bioinformatics, where he explored the integration of biology with computational technologies. This academic progression culminated in a doctoral degree in Nutrition Biology from the Central University of Haryana, where he investigated nutraceutical compounds, molecular therapeutics, and bioinformatics-based approaches to health and nutrition. His early academic pursuits reflect a strong balance between theoretical learning, laboratory training, and computational applications in life sciences.

Professional Endeavors

Dr. Shukla’s professional career demonstrates a consistent alignment with advanced biomedical research and innovation. He began as a Research Associate and later served as a Scientist in the Department of Paediatric Cardiac Research at Sri Sathya Sai Sanjeevani Research Foundation, contributing to projects on congenital heart diseases and molecular mapping of environmental toxicants. His current role as Scientist-B in the Multidisciplinary Research Unit at Dr. Bhimrao Ramji Ambedkar Government Medical College, Kannauj, highlights his continued commitment to translational biomedical research. Alongside, he has engaged in teaching and faculty development programs, coordinated national scientific conclaves, and participated in capacity-building initiatives in healthcare and nutrition sciences.

Contributions and Research Focus

Dr. Shukla’s research spans a wide spectrum, encompassing structural bioinformatics, human genomics, and nutritional biology. His investigations range from identifying novel bioactive compounds in millets and medicinal plants to computationally mapping toxicants responsible for congenital disorders. His work on psychobiotics and gut-brain regulation has added new insights into neuropsychological health, while his contributions in plant-informatics shed light on the therapeutic potential of natural compounds against viral and bacterial diseases. Additionally, his focus on food-informatics and nutrigenomics has emphasized the role of probiotics, dietary fibers, and bioengineered foods in human health. Through a combination of in-silico and in-vitro studies, his work bridges computational biology with clinical and nutritional sciences.

Accolades and Recognition

Over the course of his career, Dr. Shukla has been recognized for his scientific excellence through awards, patents, and international presentations. He achieved distinction at global scientific forums, securing recognition for his molecular insights into congenital heart disease. His granted Indian patent on crab-apple-based jelly sheets demonstrates his inventive ability to connect traditional resources with modern food biotechnology. Furthermore, his peer-review contributions for high-impact journals and invited roles as a book reviewer underline his standing in the academic community. These achievements illustrate his ability to merge innovation with scholarly rigor.

Impact and Influence

The impact of Dr. Shukla’s research is evident in the interdisciplinary nature of his contributions. His computational models for drug discovery, therapeutic peptides, and congenital heart disease targets provide frameworks for future translational research. His coordination of events such as National Nutrition Month and Women in STEM conclaves reflects his commitment to societal awareness and academic empowerment. By blending computational biology with real-world health challenges, he has influenced research directions in reproductive toxicology, nutraceutical development, and environmental genomics, thereby shaping both scientific knowledge and public health practices.

Legacy and Future Contributions

Dr. Shukla’s academic and professional trajectory reflects the making of a researcher whose work is deeply rooted in societal relevance and interdisciplinary innovation. His legacy lies in advancing computational nutrition biology and medical informatics to address complex health challenges. Looking ahead, his ongoing projects on congenital heart disease, exposome mapping, and nutratherapeutics hold the promise of contributing to precision medicine and sustainable food innovations. His future contributions are likely to expand the integration of bioinformatics with clinical sciences, reinforcing his role as a bridge between molecular insights and healthcare applications.

Present Affiliation

Dr. Adarsh Kumar Shukla is currently serving as Scientist-B in the Multidisciplinary Research Unit at Dr. Bhimrao Ramji Ambedkar Government Medical College, Kannauj, Uttar Pradesh. His role reflects his dedication to advancing multidisciplinary biomedical research with a focus on translational outcomes for healthcare.

Publications

Article: Computational insights into maternal environmental pollutants and folate pathway regulation
Authors: Adarsh Kumar Shukla, Shadab Ahamad, Prachi Kukshal
Journal: Reproductive Toxicology
Year: 2025

Article: Virtual screening of potential orally active anti-bacterial compounds of finger millet
Authors: Raushan Kumar Jha, Adarsh Kumar Shukla, Anita Kumari, Ashwani Kumar
Journal: Vegetos
Year: 2024

Article: Identification of micronutrient deficiency related miRNA and their targets in Triticum aestivum using bioinformatics approach
Authors: Surbhi Panwar, Sunita Pal, Adarsh Kumar Shukla, Ashwani Kumar, Pradeep Kumar Sharma
Journal: Ecological Genetics and Genomics
Year: 2024

Article: Effect of processing techniques on functional, antioxidants, and structural properties of finger millet (Eleusine coracana) flour
Authors: Arzoo, Neeru, Adarsh Kumar Shukla, Surbhi Panwar, Ashwani Kumar
Journal: Food and Humanity
Year: 2024

Article: Nutritional evaluation of probiotics enriched rabadi beverage (PERB) and molecular mapping of digestive enzyme with dietary fibre for exploring the therapeutic potential
Authors: Prakash Yadav, Adarsh Kumar Shukla, Deepika, Neeru, Anita Kumari, Tejpal Dhewa, Ashwani Kumar
Journal: Food and Humanity
Year: 2024

Conclusion

In summary, Dr. Shukla embodies the qualities of a multidisciplinary scientist who blends innovation with social responsibility. His research not only advances scientific understanding but also carries tangible implications for human health and nutrition. With his current role in a government medical research unit and his wide-ranging expertise, he is poised to make enduring contributions to biomedical sciences, food biotechnology, and public health.

Abdelaziz Ghanemi | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Abdelaziz Ghanemi | Medicine and Dentistry | Best Researcher Award

Laval University | Canada

Author Profile

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Abdelaziz Ghanemi’s academic foundation reflects both intellectual rigor and global engagement. He graduated as the top student from the pharmacy program at Mentouri University of Constantine in Algeria. His quest for advanced scientific knowledge led him to China Pharmaceutical University, where he earned a Master of Science in Pharmacology, completing more than twice the credit requirement. His research there involved high-throughput screening for dopamine D5 receptor ligands—a project using transgenic cell lines and cutting-edge fluorescence assays. He then pursued a Ph.D. in Molecular Medicine at Laval University in Canada. His doctoral thesis was a comprehensive study of gene regulation in obesity and exercise, particularly focusing on TFF2 and SPARC, and was constructed from an impressive 27 peer-reviewed publications, marking an extraordinary achievement in biomedical research.

🧪 Professional Endeavors

Dr. Ghanemi’s professional journey spans Algeria, China, and Canada, covering a spectrum of scientific, academic, and community roles. His appointments include:

👨‍🔬 Postdoctoral Fellowships at CHU de Québec–Université Laval Research Center and LOEX Regenerative Medicine Lab, where he explored obesity, vascular calcification, and 3D bioprinting for tissue engineering.
👨‍🏫 Visiting Scholar at the University of Victoria (2024), working under Prof. Stephanie Willerth on bioprinting applications in regenerative medicine.
🔬 Research Professional at the CHUQ’s Functional Genomics and SAGE platform, applying gene expression tools to decode metabolic and ageing pathways.
🌍 Interpreter and Science Communicator, fluent in Arabic, English, French, and Chinese, enhancing cross-cultural scientific collaboration.

In addition to these, Dr. Ghanemi has participated in numerous internships, including hospital pharmacy and neurobiology labs, and taught pharmacology in China—demonstrating both practical and pedagogical expertise.

🔬 Contributions and Research Focus

Dr. Ghanemi’s research covers some of the most pressing biomedical themes of our time:

🧠 Obesity and metabolism, focusing on gene-environment interactions and exercise-induced molecular changes
💪 Regenerative medicine, especially the roles of SPARC and TFF2 in ageing, obesity, and tissue repair
🧬 Genomic and transcriptomic analysis using transgenic animal models and advanced sequencing platforms
🩺 Chronic kidney disease and mineral bone disorders, examining vitamin D pathways and Wnt/β-catenin signaling

His scholarly productivity includes over 50 scientific articles, a Google Scholar h-index of 22, and contributions to high-impact journals such as Biomedicines, Metabolites, Biology, Medicines, and Cytokine.

🏅 Accolades and Recognition

Dr. Ghanemi’s excellence has been recognized globally:

🥇 “Best Student Award” during his undergraduate pharmacy studies
🏆 Oral Presentation Award at ICOMES & AOCO 2019 in Seoul for research on SPARC and exercise
🎓 Vanier Canada Graduate Scholarship Nominee, one of Canada’s most prestigious honors
💬 “Student Seminar Award” by CHU de Québec Research Center for outstanding research communication
🏅 “I Stand With Her” Award at the Women in Medicine Summit (Chicago), honoring his advocacy for women's health
🌍 Laval University Representative at the Canadian Student Health Research Forum (2021)

These distinctions underscore both the scientific value and societal impact of his work.

🌐 Impact and Influence

Dr. Ghanemi’s influence extends beyond the laboratory. His work on exercise mimetics, bioenergetics, and gene-environment crosstalk holds implications for public health, geriatrics, and personalized medicine. As an editor for a special issue in Biomedicines (2024–2025), he is shaping academic dialogue on metabolism and tissue engineering. His editorial contributions and published opinions have influenced how we view obesity, exercise biology, and post-COVID metabolic health. His multilingual ability and international collaborations make him a bridge between cultures and scientific communities.

🔮 Legacy and Future Contributions

Dr. Ghanemi's trajectory suggests a lasting legacy in translational medicine. His integration of molecular research, clinical relevance, and public health awareness positions him to advance therapeutic development in obesity, regenerative strategies, and age-related diseases. With current projects involving SPARC’s therapeutic applications, vascular biology, and bioprinted tissues, Dr. Ghanemi is at the vanguard of modern biomedical science. His commitment to publishing, mentoring, and interdisciplinary exploration signals continued contributions to global health and scientific progress.

Publications

📄 A Single Intraperitoneal Secreted Protein Acidic and Rich in Cysteine Injection in Mice Is Towards an Exercise-like Phenotype
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Biology
Year: 2025

📄 Obesity and Bone Mineral Density Protection Paradox in Chronic Kidney Disease: Secreted Protein Acidic and Rich in Cysteine as a Piece of the Puzzle?
Authors: Abdelaziz Ghanemi, Fabrice Mac-Way
Journal: Life
Year: 2023

📄 Secreted Protein Acidic and Rich in Cysteine (SPARC) to Manage Coronavirus Disease-2019 (COVID-19) Pandemic and the Post-COVID-19 Health Crisis
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Medicines
Year: 2023

📄 Secreted Protein Acidic and Rich in Cysteine (SPARC)—Mediated Exercise Effects: Illustrative Molecular Pathways against Various Diseases
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Diseases
Year: 2023

📄 DNA Damage as a Mechanistic Link between Air Pollution and Obesity?
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Medicines
Year: 2022

Shuai Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Shuai Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

School of Medicine,Xiamen University | China

Author Profile

Scopus

📘 Early Academic Pursuits

Mr. Shuai Wang's academic journey began with a strong foundation in Biological Sciences, earning his Bachelor’s degree from Yantai University (2014–2018). He then pursued a Master’s degree in Biology (2018–2019) and a PhD in Cell Biology (2019–2023) from Xiamen University, one of China's top research institutions. This rapid academic progression reflects his commitment to understanding complex biological systems, particularly in disease mechanisms and cellular functions.

💼 Professional Endeavors

Since September 2023, Mr. Wang has served as an Assistant Researcher at the School of Medicine, First Affiliated Hospital of Xiamen University. His work spans academic and translational research in molecular biology and metabolic disorders, with an emphasis on mechanisms of thermogenesis, obesity, and chemotherapy resistance in liver cancer. Prior to this role, he gained substantial laboratory experience during his doctoral training, shaping his precision and insight in experimental design and scientific interpretation.

🔬 Contributions and Research Focus

Mr. Wang's primary research contributions revolve around metabolic regulation, adipocyte biology, and molecular signaling pathways. He has a special interest in how transcription factors like SOX4 influence the development and function of brown and beige adipose tissue, crucial for thermogenesis and metabolic health. His recent involvement in National Natural Science Foundation-funded research explores the role of DNA demethylase TET1 in chemoresistance in liver cancer—a timely and impactful topic in cancer therapy.

🏆 Accolades and Recognition

Mr. Wang has authored several high-impact publications in prestigious journals, including:

  • Cell Death and Differentiation (2024) – as sole first author, on SOX4 and brown fat development

  • Journal of Cardiovascular Medicine and Cardiology (2024) – sole first author, linking obesity to cardiovascular diseases

  • iScience (2023) and Theranostics (2022) – as co-first author, detailing SOX4’s role in white adipose tissue and adaptive thermogenesis

  • Food Chemistry (2025) – as co-corresponding author, exploring antioxidant mechanisms via computational chemistry

These publications establish his reputation as a rising researcher with both depth and interdisciplinary reach.

🌍 Impact and Influence

Through his pioneering research in thermogenic gene regulation and molecular metabolism, Mr. Wang contributes directly to the fields of metabolic disease, obesity treatment, and precision oncology. His research not only enhances our understanding of adipocyte biology but also opens doors to innovative therapies for chronic diseases and cancer.

🧭 Legacy and Future Contributions

With a promising start as an independent researcher and a growing portfolio of impactful publications, Mr. Shuai Wang is poised to become a leading figure in biomedical research. His future work is expected to deepen the mechanistic understanding of metabolic health and cancer resistance, while inspiring collaborations across disciplines like biomedicine, pharmacology, and computational biology.

Publications

📝 Synergistic effects of polymethoxyflavonoids from citrus peel extracts on harmful compound formation and flavor quality in grilled beef patties

  • Authors: Z. Huang, Y. Xu, S. Wang, W. Quan

  • Journal: Food Chemistry

  • Year: 2025

📝 SOX4 facilitates brown fat development and maintenance through EBF2-mediated thermogenic gene program in mice

  • Authors: Shuai Wang, Ting He, Ya Luo, Kexin Ren, Huanming Shen, Lingfeng Hou, Yixin Wei, Tong Fu, Wenlong Xie, Peng Wang, Jie Hu, Yu Zhu, Zhengrong Huang, Qiyuan Li, Weihua Li, Huiling Guo, Boan Li

  • Journal: Cell Death and Differentiation

  • Year: 2024

📝 Obesity: A Key Causative Factor in Cardiovascular Disease Development

  • Authors: Shuai Wang, Ting He, Chunli Mo, Kangfeng Lin, Cui Yang, Weihua Li

  • Journal: Journal of Cardiovascular Medicine and Cardiology

  • Year: 2024

📝 Suppression of preadipocyte determination by SOX4 limits white adipocyte hyperplasia in obesity

  • Authors: Ting He, Shuai Wang, Shengnan Li, Huanming Shen, Lingfeng Hou, Yunjia Liu, Yixin Wei, Fuan Xie, Zhiming Zhang, Zehang Zhao, Chunli Mo, Huiling Guo, Qingsong Huang, Rui Zhang, Dongyan Shen, Boan Li

  • Journal: iScience

  • Year: 2023

📝 SOX4 promotes beige adipocyte-mediated adaptive thermogenesis by facilitating PRDM16-PPARγ complex

  • Authors: Huanming Shen, Ting He, Shuai Wang, Lingfeng Hou, Yixin Wei, Yunjia Liu, Chunli Mo, Zehang Zhao, Weixin You, Huiling Guo, Boan Li

  • Journal: Theranostics

  • Year: 2022

📝 Augmenting antioxidative capacity of myosin and cytoprotective potential of myosin digestion products through the integration of crocin and crocetin: A comprehensive analysis via quantum chemical computing and molecular dynamics

  • Authors: Chaoyi Xue, Jian Zhang, Chenxia Zhang, Zhonghao Hu, Huixue Liu, Lan Mo, Maiquan Li, Aihua Lou, Qingwu Shen, Jie Luo, Shuai Wang, Wei Quan

  • Journal: Food Chemistry

  • Year: 2025

 

Vishal Srivastava | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Vishal Srivastava | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Cleveland Clinic | United States

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 🎓

Dr. Vishal Srivastava’s journey in academia began with a strong foundation in his chosen field of study. His passion for scientific exploration was evident from an early stage, as he pursued rigorous academic training. Excelling in his undergraduate and postgraduate studies, he displayed an exceptional ability to understand complex scientific concepts. His pursuit of higher education led him to specialize in cutting-edge research areas, setting the stage for his remarkable contributions to academia and industry.

Professional Endeavors 💼

With a solid academic background, Dr. Vishal Srivastava embarked on a distinguished professional career, contributing his expertise to both academic institutions and research organizations. Over the years, he has taken on key roles that allowed him to bridge the gap between theoretical knowledge and practical applications. His leadership in various projects has been instrumental in shaping advancements within his domain, and his contributions continue to impact the scientific community.

Contributions and Research Focus 🔬

Dr. Vishal Srivastava has dedicated his research efforts to groundbreaking studies that have significantly advanced knowledge in his field. His work spans multiple innovative areas, focusing on addressing real-world challenges through scientific inquiry and technological solutions. With a keen interest in emerging trends, he has contributed to numerous publications and research collaborations, further solidifying his reputation as a thought leader. His research findings have not only added to academic literature but have also been applied in practical scenarios, demonstrating the real-world relevance of his work.

Accolades and Recognition 🏆

Dr. Vishal Srivastava’s contributions have been widely acknowledged, earning him prestigious accolades and recognitions from academic and professional organizations. His work has been featured in esteemed journals, and he has received awards for his pioneering research. These honors reflect his dedication, perseverance, and commitment to advancing knowledge in his field. His reputation as a scholar and innovator continues to grow as he receives invitations to share his insights at conferences, workshops, and industry events.

Impact and Influence 🌍

Beyond his research and professional achievements, Dr. Vishal Srivastava has played a crucial role in mentoring young researchers and students. His guidance has inspired many to explore new ideas and push the boundaries of conventional knowledge. His contributions extend beyond academia, as he actively collaborates with industry partners to bring research-driven innovations into real-world applications. Through his work, he has influenced policies, technological developments, and scientific progress, leaving a lasting impact on the field.

Legacy and Future Contributions 🚀

Dr. Vishal Srivastava’s legacy is one of innovation, excellence, and dedication to the pursuit of knowledge. As he continues his journey, he remains committed to pioneering research that addresses pressing global challenges. His future endeavors promise to bring further advancements, making significant contributions to science and technology. Through his ongoing work, he will continue to inspire future generations, shaping the future of research and innovation.

Publications

  •  📄Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion
    Journal: Biomolecules
    Year: 2025
    Authors: Vishal Srivastava, Zhigang Liu, Wei Wei, Yuan Zhang, James C. Paton, Adrienne W. Paton, Tingwei Mu, Bin Zhang

  •  📄 Mammalian Cargo Receptors for Endoplasmic Reticulum-to-Golgi Transport: Mechanisms and Interactions
    Journal: Biochemical Society Transactions
    Year: 2023
    Authors: Zhang Y, Srivastava V, Zhang B

  •  📄 The Combined Escherichia coli Nissle 1917 and Tryptophan Treatment Modulates Immune and Metabolome Responses to Human Rotavirus Infection in a Human Infant Fecal Microbiota Transplanted Malnourished Gnotobiotic Pig Model
    Journal: mSphere
    Year: 2022
    Authors: Michael H, Srivastava V, Deblais L, Amimo JO, Chepngeno J, Saif LJ, Rajashekara G, Vlasova AN

  •  📄 Obese Children Gut Microbiota Influences Inflammatory Mucosal Immune Pathways in the Respiratory Tract to Influenza Virus Infection: Optimization of an Ideal Duration of Microbial Colonization in a Gnotobiotic Pig Model
    Journal: Microbiology Spectrum
    Year: 2022
    Authors: Renu S, Deblais L, Patil V, Schrock J, Kathayat D, Srivastava V, Feliciano-Ruiz N, Han Y, Ramesh A, Lakshmanappa Y S, Ghimire S, Dhakal S, Rajashekara G, Renukaradhya G J

  •  📄 Evaluation of Novel Quorum Sensing Inhibitors Targeting Autoinducer 2 (AI-2) for the Control of Avian Pathogenic Escherichia coli Infections in Chickens
    Journal: Microbiology Spectrum
    Year: 2022
    Authors: Helmy Y A, Kathayat D, Deblais L, Srivastava V, Closs G, Tokarski IIR J, Ayinde O, Fuchs J R, Rajashekara G

 

Peng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Prof. Peng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Qingdao University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Peng Chen's journey in medical research began with a strong foundation in clinical medicine and biomedical sciences. She earned her Bachelor of Medicine degree from Taishan Medical College (1999-2004), where she gained essential medical knowledge and clinical training. Her pursuit of advanced expertise led her to Capital University of Medical Sciences (2004-2007), where she obtained a Master of Science degree, focusing on medical research methodologies and specialized clinical studies. To further deepen her understanding and expertise, she pursued a Doctor of Medicine (2009-2012) at Qingdao University, refining her specialization in ophthalmology and regenerative medicine.

Professional Endeavors 🔬

After completing her master's degree, Prof. Chen embarked on her professional career at the Shandong Eye Institute (2007-2016), a renowned institution dedicated to ophthalmology research. During her tenure, she made significant contributions to vision sciences and ocular disease research, strengthening her expertise in eye-related disorders. In 2016, she transitioned to Qingdao University, where she currently serves as a leading researcher and faculty member. Her role at the university allows her to conduct cutting-edge research on ophthalmology and liver regeneration, mentor young medical scientists, and contribute to the advancement of medical science.

Contributions and Research Focus 🔍

Prof. Chen's research has significantly impacted liver regeneration, macrophage efferocytosis, and ophthalmology, particularly in understanding cellular mechanisms and disease pathophysiology. Some of her key contributions include:

  • Liver Regeneration and Macrophage Efferocytosis: Her recent studies have explored the NLRP3 inflammasome's role in constraining liver regeneration by impairing macrophage efferocytosis (Sci Adv., 2025). Additionally, she has investigated the role of Aquaporin-5 in facilitating liver regeneration via the ROS/GSDMD pathway (Cell Signal., 2025) and how extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury (Cell Death Discov., 2024).
  • Ophthalmology and Ocular Disease Research: She has studied the retinoic acid synthesis pathway in AQP5-deficient mice and its implications for dry eye disease (Invest Ophthalmol Vis Sci., 2024). Her research has also examined the regulation of axon guidance by Slit2 and Netrin-1 signaling in lacrimal gland development (Invest Ophthalmol Vis Sci., 2023).

Prof. Chen’s research not only deepens scientific knowledge in these areas but also paves the way for novel therapeutic strategies for liver and eye diseases.

Accolades and Recognition 🏆

Prof. Chen’s contributions to medical science have been widely recognized through prestigious research grants and peer-reviewed publications. She has received:

  • National Natural Science Foundation of China (2020-2023): RMB 550,000 for research on AQP5’s protective role in lens transparency through miRNA-mediated autophagy.
  • Shandong Provincial Natural Science Foundation (2018-2021): RMB 150,000 for the identification and functional study of Fuchs corneal endothelial dystrophy gene.

Her research has been featured in top-tier scientific journals, including Science Advances, Cell Signal, Cell Death Discovery, and Investigative Ophthalmology & Visual Science, reinforcing her status as a leading expert in regenerative medicine and ophthalmology.

Impact and Influence 🌍

Prof. Chen’s work bridges fundamental research and clinical applications, making a profound impact in both ophthalmology and liver disease treatment. Her findings on macrophage efferocytosis and aquaporins have opened new avenues for therapeutic interventions in liver regeneration, while her contributions to ocular disease mechanisms have enhanced the understanding of corneal and lacrimal gland pathophysiology.

Through her mentorship, collaborations, and academic contributions, she continues to shape the next generation of medical researchers and clinicians, strengthening Qingdao University’s reputation as a hub for medical research excellence.

Legacy and Future Contributions 🚀

With an established track record in liver regeneration and ophthalmic research, Prof. Peng Chen’s future contributions are expected to drive medical innovations in regenerative medicine and precision healthcare. Her work on cellular signaling pathways, extracellular vesicles, and aquaporins will likely inspire new therapeutic breakthroughs in both systemic and ocular diseases. As she continues to lead cutting-edge research, mentor young scientists, and contribute to transformative discoveries, Prof. Chen’s legacy will be one of scientific excellence, innovation, and meaningful impact on global healthcare.

Publications

  • 📄NLRP3 inflammasome constrains liver regeneration through impairing MerTK-mediated macrophage efferocytosis

    • Journal: Science Advances
    • Year: 2025
    • Authors: Wei S, Guan G, Luan X, Yu C, Miao L, Yuan X, Chen P*, Di G*

  • 📄Aquaporin-5 facilitates liver regeneration following hepatectomy via ROS/GSDMD pathway

    • Journal: Cell Signaling
    • Year: 2025
    • Authors: Li B, Di G, Ge H, Song P, Han W, Sun H, Wang D, Chen P*, Wang Y*

  • 📄Extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury by enhancing macrophage efferocytosis via MerTK-ERK-COX2 signaling

    • Journal: Cell Death Discovery
    • Year: 2024
    • Authors: Miao L, Yu C, Guan G, Luan X, Jin X, Pan M, Yang Y, Yan J, Chen P*, Di G*

  • 📄Reticulated Retinoic Acid Synthesis is Implicated in the Pathogenesis of Dry Eye in Aqp5 Deficiency Mice

    • Journal: Investigative Ophthalmology & Visual Science
    • Year: 2024
    • Authors: Ge H, Di G, Li B, Han W, Song P, Han S, Wang D*, Chen P*

  • 📄Regulation of Axon Guidance by Slit2 and Netrin-1 Signaling in the Lacrimal Gland of Aqp5 Knockout Mice

    • Journal: Investigative Ophthalmology & Visual Science
    • Year: 2023
    • Authors: Bai Y, Di G, Ge H, Li B, Zhang K, Zhang D, Wang D*, Chen P*

 

Bin Zheng | Biomedicine | Best Researcher Award

Published on by Book of Award

Prof. Dr. Bin Zheng | Biomedicine | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🌱

Prof. Dr. Bin Zheng’s academic journey began with a solid foundation in medical engineering and translational medicine. He further honed his expertise as a postdoctoral fellow at the Caroline School of Medicine, Sweden, laying the groundwork for a prolific career. His early pursuits in biomaterials and nanotechnology provided a strong base for his subsequent innovations and contributions to biomedical sciences.

Professional Endeavors 🏢

As a professor at Tianjin University's Academy of Medical Engineering and Translational Medicine, Dr. Zheng has led numerous research projects, including 10 completed and 6 ongoing endeavors. With over 30 impactful SCI publications, his work has gained recognition on a global scale. His collaborations with leading companies have fostered breakthroughs in cellular manufacturing and delivery technologies, enhancing both academic and industrial applications.

Contributions and Research Focus 🔬

Dr. Zheng’s work spans a wide range of fields, including biomaterials, cancer research, cellular microbiology, immunity, and nanobiotechnology. He has developed innovative therapeutic agents, including a nebulizable anti-bacterial spray targeting exosomes and stem cell extracts. His patents—70 published and 14 in progress—reflect his commitment to bridging the gap between laboratory research and clinical application.

Accolades and Recognition 🏆

Dr. Zheng’s outstanding contributions have earned him numerous awards, such as the Excellent Doctoral Dissertation of Tianjin Municipality and the First Prize for Innovative Achievements from the China Industry-University-Research Cooperation Association. Under his mentorship, graduate students have garnered over 20 prestigious awards, solidifying his role as an influential academic leader.

Impact and Influence 🌍

His research has been clinically translated and widely reported by media outlets like Science and Technology Daily and Science Net. As an editorial board member of prestigious journals, Dr. Zheng also influences the direction of global biomedical research. His international collaborations and contributions to standards like the Belt and Road LSEA 0006-2022 standard underscore his global impact.

Legacy and Future Contributions 🌟

Prof. Dr. Bin Zheng’s legacy lies in his innovative methodologies and translational focus, which continue to inspire the next generation of researchers. With ongoing projects in cutting-edge fields like optogenetics and cellular precision manufacturing, his future contributions are set to redefine the boundaries of medical engineering and translational medicine.

 

Publications

📄 Microorganism microneedle micro-engine depth drug delivery
Author(s): Zheng, B., Li, Q., Fang, L., Cheng, S.-X., Zhang, X.
Journal: Nature Communications
Year: 2024

📄 Near-infrared remote triggering of bio-enzyme activation to control intestinal colonization by orally administered microorganisms
Author(s): Sun, W., Yun, F., Guo, Q., Zheng, B., Ruan, X.
Journal: Acta Biomaterialia
Year: 2024

📄 Surface nanocoating-based universal platform for programmed delivery of microorganisms in complicated digestive tract
Author(s): Du, Y., Guo, H.L., Su, X., Wang, T., Zheng, B.
Journal: Journal of Colloid and Interface Science
Year: 2024

📄 A self-assembling bioactive oligopeptide hydrogel for the treatment of edema following prepuce surgery
Author(s): Liu, J., Pei, Y., Huang, Y., Chen, L., Zhou, Y.
Journal: Journal of Materials Chemistry B
Year: 2024

📄 NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain
Author(s): Han, H., Li, B., Yang, R., Bai, Y., Yu, Y.
Journal: ACS Biomaterials Science and Engineering
Year: 2024

 

Jillian Perry | Materials Science | Best Researcher Award

Published on by Book of Award

Assist Prof Dr. Jillian Perry | Materials Science | Best Researcher Award

University of North Carolina - Chapel Hill | United States

Author Profile

Google Scholar

🧠 Early Academic Pursuits

Assist. Prof. Dr. Jillian Perry's academic journey began with a Bachelor of Science in Chemical Engineering, awarded Cum Laude from the University of Florida in 2004, with a minor in Chemistry. Building on her solid foundation, she pursued a PhD in Biomedical Engineering at the same university, where she conducted pioneering research on chitosan nanotube synthesis for drug delivery applications. Her dissertation, supervised by Dr. John D. Steward and Dr. Charles R. Martin, laid the groundwork for a career focused on innovative solutions in drug delivery and nanotechnology.

💼 Professional Endeavors

Currently an Assistant Professor at the University of North Carolina’s Eshelman School of Pharmacy, Dr. Perry also contributes to the Center for Nanotechnology in Drug Delivery. Since joining UNC in 2010 as a Postdoctoral Research Associate at the Lineberger Comprehensive Cancer Center, she has been mentored by renowned researchers like Dr. Joseph M. DeSimone. Over the years, she progressed from a Research Associate Scientist to her current position, collaborating on high-impact research in pharmacoengineering and molecular pharmaceutics.

🧬 Contributions and Research Focus

Dr. Perry’s research explores 3D-printed microneedles, transdermal drug delivery systems, and nanoparticle-based cancer immunotherapies. She has authored numerous impactful publications, contributing extensively to fields such as tumor targeting and transdermal vaccination techniques. Her work includes significant studies on hydrogel-based cancer treatments and PRINT nanoparticle technology for enhanced therapeutic delivery.

🏆 Accolades and Recognition

Dr. Perry has been honored with several awards, such as the 2020 Junior Faculty Development Award and the NanoDDS Poster Award in 2018. Her 3D-printed vaccine patch technology received global attention and won the Fast Company’s World Changing Ideas Award in 2022. She was also recognized for her academic excellence with prestigious scholarships like the University Scholars Scholarship and Bright Futures Scholarship during her undergraduate years.

🌍 Impact and Influence

With an H-index of 19 and over 2,130 citations, Dr. Perry’s research has influenced the scientific community's understanding of nanomedicine and drug delivery technologies. Her innovative approaches in microneedle design and 3D printing for vaccine delivery have potential applications beyond academia, transforming practical healthcare delivery methods and advancing public health initiatives worldwide.

📜 Legacy and Future Contributions

As a thought leader in nanotechnology and biopharmaceuticals, Dr. Perry is expected to continue making groundbreaking contributions to transdermal vaccine development and targeted cancer therapies. Her active role in patenting novel drug delivery systems and designing biocompatible materials solidifies her legacy as a researcher committed to pioneering health solutions. Future contributions will likely include further advancements in non-invasive drug delivery and enhanced treatment efficacy in challenging medical fields, paving the way for transformative healthcare solutions.

 

Publications

📄  Development of 3D printed microneedles of varied needle geometries and lengths, designed to improve dermal delivery of topically applied psoriasis treatments

Authors: Pünnel LC, Palmtag M, Lunter DJ, Perry JL
Journal: European Journal of Pharmaceutics and Biopharmaceutics
Year: 2024

📄  3D-printed Lattice Microneedle Array Patches for Tunable and Versatile Intradermal Delivery

Authors: Rajesh NU, Hwang J, Xu Y, Saccone MA, Hung A, Hernandez RAS, Coates IA, Driskill MM, Dulay MT, Jacobson GB, Tian S, Perry JL#, DeSimone JM
Journal: Advanced Materials
 Year: 2024

📄  Development of a biocompatible 3D hydrogel scaffold using CLIP for the delivery of cell therapy to treat recurrent glioblastoma

Authors: Kass L, Morrent T, Zhang Y, DeVane C, Logan J, Tessema A, Perry JL#, Hingtgen SD
 Journal: Bioengineering and Translational Medicine
Year: 2024

📄  3D-Printed Microarray Patches for Transdermal Applications

Authors: Rajesh NU, Coates I, Driskill MM, Dulay MT, Hsiao K, Ilyn D, Jacobson GB, Kwak JW, Lawrence M, Perry JL, Shea CO, Tian SM, DeSimone JM
 Journal: JACS Au
 Year: 2022

📄  Transdermal Vaccination via 3D Printed Microneedles Induces Potent Humoral and Cellular Immunity

Authors: Caudill CL, Perry JL, Illiadis K, Tessema AT, Lee BJ, Mecham BS, Tian S, DeSimone JM
Journal: PNAS
 Year: 2021

 

Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

University of Chieti | Italy

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Ylenia Della Rocca’s academic journey began with exceptional achievements in biotechnology. In 2018, she earned her degree in Biotechnology with a perfect score of 110/110 cum laude from the University of L'Aquila. Her thesis, centered on "Hairy Cell Leukemia," set the stage for her future in oncohematological genetics. She continued to excel with a Master’s degree in Medical Biotechnology, again graduating with academic praise. Her research on the HLA-G 3' UTR region in kidney transplantation at the National Research Center solidified her expertise in medical biotechnology.

🏥 Professional Endeavors

Currently, Dr. Della Rocca serves as a Researcher Technologist and Subject Expert in Histology and Embryology at the University of Chieti. Her impressive academic trajectory culminated in a Ph.D. in "Innovative Technologies in Clinical Medicine & Dentistry" in 2024. As part of her doctoral research, she developed a new iPS cell line during her tenure at the University of Barcelona and Josep Carreras Leukaemia Research Institute. Beyond her role as a researcher, Dr. Della Rocca has been a prominent speaker at numerous international conferences, where her work has garnered significant recognition.

🔬 Contributions and Research Focus

Dr. Della Rocca’s research is at the forefront of biotechnology and regenerative medicine. Her completed and ongoing projects include the development of three-dimensional disease models, studies on tissue differentiation, and the establishment of new iPS cell lines. She has also been pivotal in creating innovative models for carcinogenesis research. Her current patent under review—"Pluripotent Stem Cells Induced by Autologous Gingival Stem Cells and Extracellular Vesicles: A Novel Approach for Cardiac Regeneration"—underscores her groundbreaking contributions to stem cell therapies and regenerative medicine.

🏆 Accolades and Recognition

Dr. Della Rocca’s research career has been marked by numerous accolades, including two prestigious awards for her scientific achievements. She has been a Guest Editor for special issues in renowned journals like the International Journal of Molecular Sciences and has served as a Review Editor for Frontiers in Genetics and Frontiers in Cell and Developmental Biology. Her citation index of 10 reflects the growing impact of her research in the scientific community.

🌍 Impact and Influence

Dr. Della Rocca’s work transcends academic research, as evidenced by her collaborations with top universities and research institutes worldwide, including the University of Barcelona, IRCCS Sicily, and the University of Montreal. She is an active member of the Italian Society of Anatomy and Histology and the Sigma Xi Scientific Research Honor Society. Dr. Della Rocca’s commitment to healthcare is further exemplified by her founding of Associazione Sorrisi in Ospedale (A.S.I.O.), a third-sector organization aimed at improving patient care in hospitals.

🔮 Legacy and Future Contributions

As a leader in the fields of stem cells, bioengineering, and regenerative medicine, Dr. Ylenia Della Rocca continues to push the boundaries of scientific knowledge. Her contributions to cell-free therapies and the development of three-dimensional models hold immense promise for future medical applications. With her ongoing work in stem cell regeneration and epigenetic research, Dr. Della Rocca is poised to shape the next frontier of clinical and research tools, leaving a lasting legacy in biotechnology.

 

Publications

📄 Autologous hGMSC-Derived iPS: A New Proposal for Tissue Regeneration
Authors: Ylenia Della Rocca, Francesca Diomede, Fanì Konstantinidou, Valentina Gatta, Liborio Stuppia, Umberto Benedetto, Marco Zimarino, Paola Lanuti, Oriana Trubiani, Jacopo Pizzicannella
Journal: International Journal of Molecular Sciences
Year: 2024

📄 Biological Effects of PMMA and Composite Resins on Human Gingival Fibroblasts: An In Vitro Comparative Study
Authors: Ylenia Della Rocca, Enrico Matteo Traini, Oriana Trubiani, Tonino Traini, Antonella Mazzone, Guya Diletta Marconi, Jacopo Pizzicannella, Francesca Diomede
Journal: International Journal of Molecular Sciences
Year: 2024